Method of screening for agents that modulate Tysnd1 level or activity in a cell.
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 20, 2009
Grant Date -
Jul 3, 2008
app pub date -
Dec 10, 2007
filing date -
Jun 9, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to a pharmaceutical composition for treating or diagnosing a disorder associated with production of peroxisome in a cell, comprising a polypeptide which has cysteine protease activity and directly processes peroxisomal enzymes targeted by PTS1 or PTS2 signals. Preferably, the polypeptide is encoded by Tysnd1.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully